Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jelena Belic

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Advances in Clinical Chemistry|April 23, 2017
Advances in Circulating Tumor DNA AnalysisSamantha Perakis, Martina Auer, Jelena Belic, et al.
Cancers|June 11, 2020
Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall SurvivalChantal Bourrier, Jean-Yves Pierga, Laura Xuereb, et al.
International Journal of Cancer|September 19, 2020
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot studyMatthias Unseld, Jelena Belic, Kerstin Pierer, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNAJelena Belic, Marina Koch, Peter Ulz, et al.
Clinical Chemistry|April 22, 2015
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS ApproachJelena Belic, Marina Koch, Peter Ulz, et al.
Clinical Chemistry|April 9, 2020
Detection of ctDNA from Dried Blood Spots after DNA Size SelectionKatrin Heider, Jonathan C M Wan, James Hall, et al.
EMBO Molecular Medicine|June 13, 2022
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft modelsCarolin M Sauer, Katrin Heider, Jelena Belic, et al.
Nature Communications|June 23, 2016
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancerPeter Ulz, Jelena Belic, Ricarda Graf, et al.
International Journal of Cancer|March 26, 2018
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamideJelena Belic, Ricarda Graf, Thomas Bauernhofer, et al.
NPJ Precision Oncology|December 10, 2020
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancerTina Moser, Julie Waldispuehl-Geigl, Jelena Belic, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Advances in Clinical Chemistry|April 23, 2017
Advances in Circulating Tumor DNA AnalysisSamantha Perakis, Martina Auer, Jelena Belic, et al.
Cancers|June 11, 2020
Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall SurvivalChantal Bourrier, Jean-Yves Pierga, Laura Xuereb, et al.
International Journal of Cancer|September 19, 2020
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot studyMatthias Unseld, Jelena Belic, Kerstin Pierer, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNAJelena Belic, Marina Koch, Peter Ulz, et al.
Clinical Chemistry|April 22, 2015
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS ApproachJelena Belic, Marina Koch, Peter Ulz, et al.
Clinical Chemistry|April 9, 2020
Detection of ctDNA from Dried Blood Spots after DNA Size SelectionKatrin Heider, Jonathan C M Wan, James Hall, et al.
EMBO Molecular Medicine|June 13, 2022
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft modelsCarolin M Sauer, Katrin Heider, Jelena Belic, et al.
Nature Communications|June 23, 2016
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancerPeter Ulz, Jelena Belic, Ricarda Graf, et al.
International Journal of Cancer|March 26, 2018
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamideJelena Belic, Ricarda Graf, Thomas Bauernhofer, et al.
NPJ Precision Oncology|December 10, 2020
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancerTina Moser, Julie Waldispuehl-Geigl, Jelena Belic, et al.
Pageof 2